COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1415-1425

  Liu, Yuelong ^a   Shah, Spandan V ^a   Xiang, Xiaoyu ^a   Wang, Jianhua ^a   Deng, Zhong Bin ^a   Liu, Cunren ^a   Zhang, Liming ^a   Wu, Jianming ^a   Edmonds, Tara ^c   Jambor, Christina ^d   Kappes, John C ^b,c,d,e   Zhang, Huang Ge ^a,e,f  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COP9 SIGNALOSOME; HEAT SHOCK PROTEIN 70; SMALL INTERFERING RNA; COPS5 PROTEIN, HUMAN; GAG PROTEIN; HIV GAG P24 PROTEIN (29 60); HIV GAG P24 PROTEIN (29-60); MULTIPROTEIN COMPLEX; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; EXOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; UBIQUITINATION; WESTERN BLOTTING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

BLOTTING, WESTERN; EXOSOMES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPROTEIN COMPLEXES; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTEIN TRANSPORT; PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITINATION;

EID: 65349196684     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080861     Document Type: Article

References (62)

1. Keller S, Sanderson MP, Stoeck A, Altevogt P: Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006, 107:102-108
2. Schorey JS, Bhatnagar S: Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9:871-881
3. van Niel G, Porto-Carreiro I, Simoes S, Raposo G: Exosomes: a common pathway for a specialized function. J Biochem 2006, 140:13-21
4. Katzmann DJ, Babst M, Emr SD: Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex. ESCRT-I, Cell 2001, 106:145-155
5. Nguyen DG, Booth A, Gould SJ, Hildreth JE: Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 2003, 278:52347-52354
6. Fang Y, Wu N, Gan X, Yan W, Morrell JC, Gould SJ: Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 2007, 5:e158
7. Zeilfelder U, Frank O, Sparacio S, Schon U, Bosch V, Seifarth W, Leib-Mosch C: The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines. Gene 2007, 390:175-179
8. Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD: Escrt- III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell 2002, 3:271-282
9. Pelchen-Matthews A, Raposo G, Marsh M: Endosomes, exosomes and Trojan viruses. Trends Microbiol 2004, 12:310-316
10. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247
11. Callige M, Kieffer I, Richard-Foy H: CSN5/Jab1 is involved in ligand- dependent degradation of estrogen receptor {alpha} by the protea- some. Mol Cell Biol 2005, 25:4349-4358
12. Dai YS, Hao J, Bonin C, Morikawa Y, Cserjesi P: JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding. J Neurosci Res 2004, 76:613-622
13. Doronkin S, Djagaeva I, Beckendorf SK: CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint. Development 2002, 129:5053-5064
14. Harari-Steinberg O, Cantera R, Denti S, Bianchi E, Oron E, Segal D, Chamovitz DA: COP9 signalosome subunit 5 (CSN5/Jab1) regulates the development of the Drosophila immune system: effects on Cactus. Dorsal and hematopoiesis, Genes Cells 2007, 12:183-195
15. Kim JV, Latouche JB, Riviere I, Sadelain M: The ABCs of artificial antigen presentation. Nature Biotechnol 2004, 22:403-410
16. Luo W, Wang Y, Hanck T, Stricker R, Reiser G: Jab1, a novel pro- tease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. J Biol Chem 2006, 281:7927-7936
17. Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW, Song J: Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 2006, 281:17457-17465
18. Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N: The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood 2005, 105:775-783
19. Wang J, Li C, Liu Y, Mei W, Yu S, Liu C, Zhang L, CaoX, Kimberly RP, Grizzle W, Zhang HG: JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-alpha. Am J Pathol 2006, 169:889-902
20. Wei N, Deng XW: The COP9 signalosome. Annu Rev Cell Dev Biol 2003, 19:261-286
21. Glickman MH, Rubin DM, Fried VA, Finley D: The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol 1998, 18:3149-3162
22. Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu W, Cohen RE, Shi Y: Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002, 111:1041-1054
23. Verma R, Aravind L, Oania R, McDonald WH, Yates JR, 3rd, Koonin EV, Deshaies RJ: Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome, Science 2002, 298:611-615
24. Cope GA, Deshaies RJ: Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels, BMC Biochem 2006, 7:1-10
25. Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ: Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1, Science 2002, 298:608-611
26. Schwechheimer C: The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim Biophys Acta 2004, 1695:45-54
27. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG: Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006, 176:1375-1385
28. Zhang HG, Hanson LA: Deletion of thymidine kinase gene attenuates channel catfish herpesvirus while maintaining infectivity, Virology 1995, 209:658-663
29. Hallstrom TC, Nevins JR: Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev 2006, 20:613-623
30. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM: Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci USA 2004, 101:4204-4209
31. Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L, Li C, Cong Y, Kimberly R, Grizzle WE, Falkson C, Zhang HG: Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007, 178:6867-6875
32. Buschow SI, Liefhebber JM, Wubbolts R, Stoorvogel W: Exosomes contain ubiquitinated proteins. Blood Cells Mol Dis 2005, 35:398-403
33. Whitby FG, Xia G, Pickart CM, Hill CP: Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem 1998, 273:34983-34991
34. Agromayor M, Martin-Serrano J: Interaction of AMSH with ESCRT- III and deubiquitination of endosomal cargo. J Biol Chem 2006, 281:23083-23091
35. Jager S, Gottwein E, Krausslich HG: Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol 2007, 81:9193-9201
36. Klinger PP, Schubert U: The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy. Expert Rev Anti Infect Ther 2005, 3:61-79
37. Mazze FM, Degreve L: The role of viral and cellular proteins in the budding of human immunodeficiency virus. Acta Virol 2006, 50:75-85
38. Ott DE, Coren LV, Chertova EN, Gagliardi TD, Schubert U: Ubiquiti- nation of HIV-1 and MuLV Gag. Virology 2000, 278:111-121
39. Cunningham AL, Dwyer DE, Dowton DN: Viral markers in HIV infection and AIDS. J Acquir Immune Defic Syndr 1993, 6:S32-S35
40. Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W: HIV-1 viral load assays for resource-limited settings. PLoS Med 2006, 3:e417
41. Ono A, Freed EO: Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J Virol 2004, 78:1552-1563
42. Saag MS: Use of virologic markers in clinical practice. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:S3-S13
43. Katzmann DJ, Sarkar S, Chu T, Audhya A, Emr SD: Multivesicular body sorting: ubiquitin ligase Rsp5 is required for the modification and sorting of carboxypeptidase S. Mol Biol Cell 2004, 15:468-480
44. Oestreich AJ, Aboian M, Lee J, Azmi I, Payne J, Issaka R, Davies BA, Katzmann DJ: Characterization of multiple multivesicular body sorting determinants within Sna3: a role for the ubiquitin ligase Rsp5. Mol Biol Cell 2007, 18:707-720
45. Pornillos O, Higginson DS, Stray KM, Fisher RD, Garrus JE, Payne M, He GP, Wang HE, Morham SG, Sundquist WI: HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol 2003, 162:425-434
46. Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Drapkin R, Kisselev AF, Tanaka K, Nakatani Y: The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003, 113:357-367
47. Bultmann A, Eberle J, Haas J: Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein. J Virol 2000, 74:5373-5376
48. Keenan J, Oliaro J, Domigan N, Potter H, Aitken G, Allardyce R, Roake J: Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun 2000, 68:3337-3343
49. Ott DE, Coren LV, Copeland TD, Kane BP, Johnson DG, Sowder RC, 2nd, Yoshinaka Y, Oroszlan S, Arthur LO, Henderson LE: Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J Virol 1998, 72:2962-2968
50. Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC: Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo. Clin Cancer Res 2008, 14:4045-4052
51. Wang J, Barnes RO, West NR, Olson M, Chu JE, Watson PH: Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer. Breast Cancer Res 2008, 10:R51
52. Hsu MC, Chai CY, Hou MF, Chang HC, Chen WT, Hung WC: Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Mod Pathol 2008, 21:609-616
53. Hsu MC, Chang HC, Hung WC: HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr Relat Cancer 2007, 14:655-667
54. Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schafer N, Holler TT, Fischer HP, Buttner R, Gutgemann I: Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Hum Pathol 2007, 38:1621-1627
55. Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y: Overexpression of Jun activation domain- binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer 2006, 107:154-161
56. Harada K, Kawashima Y, Yoshida H, Sato M: High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation. Anticancer Res 2006, 26:1615-1619
57. Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M: Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep 2006, 15:765-771
58. Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M: Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clin Cancer Res 2005, 11:259-266
59. Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y: Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol Rep 2004, 11:277-284
60. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L: Tumor- released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915
61. Taylor DD, Akyol S, Gercel-Taylor C: Pregnancy-associated exo- somes and their modulation of T cell signaling. J Immunol 2006, 176:1534-1542
62. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001, 7:297-303